On February 14, 2023, Apexigen, Inc. closed the transaction. The transaction included participation from 13 investors. The company paid cash Sales Commissions of $195579 and finder's fee of $45,000.
1st Jan change | Capi. | |
---|---|---|
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B |